de Aretxabala Xabier, Roa Ivan, Burgos Luis, Losada Hector, Roa Juan Carlos, Mora Javier, Hepp Juan, Leon Jorge, Maluenda F
Department of Surgery, German Clinic, Vitacura 5951, Santiago, Chile.
J Gastrointest Surg. 2006 Feb;10(2):186-92. doi: 10.1016/j.gassur.2005.11.003.
The goal was to study our experience in the management of a series of patients with a potentially curative subserosal gallbladder cancer who were prospectively treated by the authors. Between April 1988 and July 2004, 139 patients were enrolled in our prospective database. Of the above, 120 were operated on with an open procedure and the rest with laparoscopic surgery. In only eight patients was the diagnosis suspected before the cholecystectomy. The majority of tumors were adenocarcinoma. Six patients had an epidermoid tumor, and one had a carcinosarcoma. Of the patients, 74 underwent reoperation, while in 55 (70.2%) it was possible to perform an extended cholecystectomy with a curative aim. Operative mortality was 0%, and operative morbidity was 16%. Lymph node metastases were found in 10 (18.8%), while in 7 (13.2%) the liver was involved. The overall survival rate was 67.7%, while in those who underwent resection, the survival rate was 77%. Through the use of a multivariate analysis, the presence of lymph node metastasis was found to be an independent factor with respect to prognosis. The feasibility of performing an extended cholecystectomy in patients with gallbladder cancer and invasion of the subserosal layer allows for a good survival rate. The presence of lymph node metastases represents the main poor prognosis factor, and some type of adjuvant therapy should be studied in this particular group.
目的是研究作者对一系列具有潜在治愈可能的浆膜下胆囊癌患者进行前瞻性治疗的经验。1988年4月至2004年7月期间,139例患者被纳入我们的前瞻性数据库。其中,120例行开放手术,其余行腹腔镜手术。仅8例患者在胆囊切除术前被怀疑诊断。大多数肿瘤为腺癌。6例为表皮样肿瘤,1例为癌肉瘤。患者中,74例行再次手术,而55例(70.2%)有可能进行旨在治愈的扩大胆囊切除术。手术死亡率为0%,手术发病率为16%。发现10例(18.8%)有淋巴结转移,7例(13.2%)有肝转移。总生存率为67.7%,而行切除术患者的生存率为77%。通过多因素分析发现,淋巴结转移的存在是影响预后的独立因素。对胆囊癌侵犯浆膜下层的患者进行扩大胆囊切除术具有可行性,可获得良好的生存率。淋巴结转移的存在是主要的预后不良因素,应对这一特定群体研究某种类型的辅助治疗。